Xponential Fitness, Inc. XPOF
3.92
0.17
4.53%
as of 25 Sep
- Market cap
- $184.7M
- P/E
- 0.0×
Follow XPOF
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.01 | 0.75 | 0.91 | 0.87 | |
P/FCF ratio |
0.00 | 94.35 | 9.60 | 17.26 | |
P/Operating CF |
(72.03) | (10.36) | 26.83 | 29.41 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.71 | 2.37 | 2.37 | 1.88 | |
EV/EBITDA |
15.07 | 9.74 | 10.29 | 9.85 | |
EV/Operating CF |
(135.76) | 873.52 | 26.36 | 32.10 | |
EV/FCF |
(271.53) | 297.53 | 25.01 | 37.31 | |
Quick Ratio |
0.46 | 0.43 | 0.55 | 0.64 | |
Current Ratio |
0.75 | 0.76 | 0.82 | 1.06 | |
Net Debt/EBITDA |
40.27 | 29.95 | 16.02 | (60.71) | |
Debt/Assets |
166.14% | 156.71% | 146.33% | 101.05% | |
Debt/Equity |
(1.37) | (1.36) | (1.36) | (1.12) | |
Asset Turnover |
0.81 | 0.81 | 0.84 | 0.76 | |
Operating CF/Net income |
0.98 | 29.92 | (0.24) | (1.91) | |
Capex/Depreciation |
(0.24) | (0.26) | 0.10 | (0.06) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
65.90% | 68.71% | 85.58% | 42.69% | |
Intangible Assets out of Total Assets |
0.62 | 0.60 | 0.56 | 0.55 | |
Share Based Compensation of Revenue |
2.58% | 3.27% | 5.50% | 3.04% | |
Graham Net Nets |
(2.12) | (2.76) | (2.17) | (2.11) | |
Graham Number |
17.20 | 17.59 | 18.74 | 18.41 | |
Earnings Yield |
(21.24%) | (22.92%) | (17.74%) | (21.18%) | |
Free Cash Flow Yield |
(0.99%) | 1.06% | 10.42% | 5.79% | |
Revenue per Share |
1.57 | 1.63 | 2.38 | 2.25 | |
Operating CF per Share |
(0.10) | (0.58) | 0.31 | 0.26 | |
Capex per Share |
(0.01) | (0.02) | 0.11 | 0.01 | |
Free Cash Flow per Share |
(0.11) | (0.60) | 0.42 | 0.28 | |
Cash per Share |
0.59 | 0.58 | 1.32 | 1.18 | |
Shareholders Equity per Share |
(8.95) | (9.97) | (10.69) | (9.13) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(8.95) | (9.97) | (10.69) | (9.13) | |
Free Cash Flow |
(4.66) | (22.51) | 14.50 | 9.80 | |
Working Capital |
(23.57) | (24.03) | (21.33) | 5.99 | |
Capital Expenditures |
(0.63) | (0.82) | 3.82 | 0.50 | |
Net Current Asset Value |
(616.55) | (619.39) | (622.94) | (576.59) | |
EV/EBIT |
43.60 | 30.52 | 37.60 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | (0.05) | (0.01) | |
Net Profit Margin |
(6.27%) | (1.19%) | (54.63%) | (6.16%) | |
Price to Operating Income |
16.25 | 9.68 | 14.43 | 0.00 | |
| Other line items | |||||
Average Receivables |
27.06 | 24.85 | 22.17 | 24.10 | |
Average Payables |
19.53 | 22.87 | 26.65 | 18.44 | |
Average Inventory |
5.17 | 5.41 | 6.12 | 8.13 | |
Average Assets |
354.83 | 367.43 | 374.52 | 413.74 | |
Average Common Equity |
(344.63) | (342.84) | (341.38) | (280.33) |
Columns are period end dates